AokiK., KondoS., SatoK..: Hypertensive action of nifedipine (Ca ++ - antagonist) and propranolol in acute trials and its long-term therapy of hypertensive coronary heart disease patients.Jap. Heart J.22: 575–584, 1981.
2.
Lederball-PedersenO., MikkelsenE., ChristiansenN.J..: Effects of nifedipine on plasma renin activity, plasma aldosterone, and plasma catecholamines in arterial hypertension.Eur. J. Clin. Pharmacol.15: 235–240, 1979.
3.
Van BreemanC., MangelA., FakimM..: Selectivity of calcium antagonistic action in vascular smooth muscle.Am. J. Cardiol.49: 407–510, 1982.
4.
AdelsteinR.S., HathawayD.R.: Role of calcium and cyclic adenosine 3′,5′-monophosphate on regulating smooth muscle contraction.Am. J. Cardiol.44: 783–787, 1979.
5.
ZeliaR., FlaimS.F.: Calcium influx blockers and vascular smooth muscle: do we really understand the mechanisms? Ann.Int. Med.94: 124–126, 1981.
ZawadaE.T., BennettE.P., JohnsonM..: The effects of changes in calcium on blood pressure in conscious dogs.Nephron33: 262–267, 1983.
8.
ZawadaE.T., JohnsonM.: Does calcium mediate high renin renal hypertension?Clin. Res.38: 467A, 1982.
9.
McCarronD.A.: Calcium and magnesium nutrition in human hypertension. Ann. Int.Med.98(Part 2): 800–805, 1983.
10.
AyachiS.: Increased dietary calcium lowers blood pressure in the spontaneously hypertensive rat.Hypertension3: 162–167, 1981.
11.
SchusederH.A.: Relation between mortality from cardiovascular disease and treated water supplies: variation in states and 163 largest municipalities in the United States.JAMA172: 1902–1908, 1968.
12.
StittF.W., CrawfordM.D., ClaytonD.G..: Clinical and biochemical indicators of cardiovascular disease among men living in hard and soft water areas.Lancet1: 122–126, 1973.
13.
AlturaB.M., AlturaB.T.: Magnesium ions and contraction of vascular smooth muscle: relationships to some vascular diseases.Fed. Proc.40: 2672–2679, 1981.
14.
AlturaB.M., AlturaB.T.: Role of magnesium ions in contractility of blood vessels and skeletal muscles.Magnesium Bulletin20: 92–96, 1981.
15.
DyknerT., WesterP.O.: Effect of magnesium on blood pressure. British Med.J.286: 1847–1849, 1983.
16.
MaroneC., Beretta-PiccoliC., WeidmannP.: Acute hypercalcemic hypertension in man: role of hemodynamics, catecholamines, and renin.Kidney Int.20: 92–96, 1981.
17.
BrintonG.S., JubizW., LagerquistL.D.: Hypertension in primary hyperparathyroidism the role of the renin angiotensin system.J. Clin. End. Metab.41: 1025–1029, 1975.
CampeseV.M., SaglikesY., BrautbarN., MassryS.G.: Effect of phosphate depletion on blood pressure.Kidney Int.23: 97, 1983.
20.
McCarronD.A., EllisonD.H., AndersonS.: Vasodilatation mediated by human PTH 1-34 in the spontaneously hypertensive rat.Am. J. Physiol.15: F96–F100, 1984.
21.
JohnsonM., MacKenzieT., ZawadaE.Jr..: Effects of increased ionized serum calcium independent of changes in parathormone on systemic and renal hemodynamics.Clin. Res.861A, 1983.
RatzeD., AugustinR., WisserH.: Catecholamines, renin, aldosterone, and arterial pressure in patients on chronic hemodialysis treatment.Int. J. Artif. Org.6: 255–260, 1983.
24.
RodrigoT., ShidemanJ., McHughR., BuselmeierT., KjellstrandC.: Osmolality changes during hemodialysis: Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol.Ann. Intern. Med.86: 544–561, 1977.
25.
KirkendolP.L., RobieN.W., GonzalesF.M., DevinC.J.: Cardiac and vascular effects of infused sodium acetate in dogs.Trans. Am. Soc. Antil. Intern. Org.24: 714–718, 1978.
26.
KennedyA.C., LintonA.L., LubeR.B., RenfrewS., DinwoddieA.: The pathogenesis and prevention of cerebral dysfunction during dialysis.Lancet1: 790–793, 1964.
27.
PickeringT.G., GriffinB., OliverD.O.: Baroreflex sensitivity in patients during long-term hemodialysis.Clin. Sci.43: 645–657, 1972.
28.
MontanianA., GrazianiG., CantaluppiA..: Skeletal muscle mineral composition in long-term hemodialysis.Bin. Elect. Metab.9: 158–184, 1983.
29.
GonellaM.: Plasma and tissue levels of magnesium in chronically hemodialyzed patients: effects of dialysate magnesium levels.Nephron34: 141–145, 1983.
30.
EricssonF., BjörnCarlmark: Potassium in whole body, skeletal muscle and erythrocytes in chronic renal failure.Nophron173–178, 1983.
31.
OhM.S., LevisonS.P., CarrollH.J.: Content and distribution of water and electrolytes in maintenance hemodialysis.Nephron14: 421–432, 1975.
32.
BouillonR., VerberckmoesR., MoorP.D.: Influence of dialysate calcium concentration on the plasma calcium fractions in patients on dialysis.Nephron16: 181–187, 1976.
33.
HenrichW., HuntJ.M., NixonJ.V.: Increased ionized calcium and left ventricular contractility during hemodialysis. New Eng.J. Med.310: 19–23, 1984.
34.
ChaignonM., ChenW.T., ToraziR.C., NakamotoS., SalcedoE.: Acute effects of hemodialysis on echographic-determined cardiac performance: improved contractility resulting from serum increased calcium with reduced potassium despite hypovolemic-reduced cardiac output.Am. Heart J.108: 374–378, 1982.
35.
HaddyF.J., ScottJ.B., EmersonT.E., OverbeckH.W., DaughertyR.M.Jr..: Effects of generalized changes in plasma electrolyte concentration and osmolality on blood pressure in the anesthetized dog. Circulation Res.(Supplement 1)24: 59–73, 1969.
36.
WeidmannP., MassryS.G., CoburnJ.W., MaxwellM.H., AtlestonJ., KleemanC.R.: Blood pressure effects of acute hypercalcemia: studies in patients with chronic renal failure.Ann. Int. Med.76: 741–745, 1972.
37.
ZawadaE.T., BennettE.B., StinsonJ.B..: The role of serum calcium in blood pressure regulation during dialysis.Arch. Int. Med.14: 657–658, 1981.
38.
SicaD.A., HardfordA.M., ZawadaE.T.: Hypercalcemic hypertension in hemodialysis.Clin. Nephrol. In Press.
